Journal of Assisted Reproduction and Genetics

, Volume 28, Issue 8, pp 669–676 | Cite as

Umbilical cord blood banking: an update

  • Merlin G. Butler
  • Jay E. Menitove
Stem cell biology



Umbilical cord blood is a potential vast source of primitive hematopoietic stem and progenitor cells available for clinical application to reconstitute the hematopoietic system and/or restore immunological function in affected individuals requiring treatment. Cord blood can be used as an alternative source for bone marrow transplantation and its use is developing into a new field of treatment for pediatric and adult patients presenting with hematological disorders, immunological defects and specific genetic diseases.


More than 25,000 allogeneic cord blood transplantations have been performed worldwide since the first cord blood transplantation in 1988. There are two banking options for storing umbilical cord blood [private (family) and public]. Cord blood stored in private banks are used for either autologous or allogeneic transplants for the infant donor or related family members but private cord blood banks are not searchable or available to the public. More than 780,000 cord blood units are stored in over 130 private cord blood banks, worldwide, and over 400,000 units in more than 100 quality controlled public cord blood banks.


Researchers continue to evaluate the usefulness of cord blood cells in treating human diseases or disorders for purposes other than hematological disorders including heart disease, strokes, brain or spinal cord injuries and cancer. This review summarizes the status of umbilical cord blood banking, its history and current and potential use in the treatment of human disease.


Umbilical cord blood Public and private cord blood banks Transplantation Clinical applications Regenerative medicine 


  1. 1.
    Hwang WY, Samuel M, Tan D, Koh LP, Lim W, Linn YC. A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients. Biol Blood Marrow Transplant. 2007;13:444–53.PubMedCrossRefGoogle Scholar
  2. 2.
    Frangoul H, Wang L, Harrell Jr FE, Manes B, Calder C, Domm J. Unrelated umbilical cord blood transplantation in children with immune deficiency: results of a multicenter study. Bone Marrow Transplant. 2010;45:283–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Prasad VK, Mendizabal A, Parikh SH, Szabolcs P, Driscoll TA, Page K, et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood. 2008;112:2979–89.PubMedCrossRefGoogle Scholar
  4. 4.
    Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 2007;369:1947–54.PubMedCrossRefGoogle Scholar
  5. 5.
    Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265–75.PubMedCrossRefGoogle Scholar
  6. 6.
    Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611–18.PubMedGoogle Scholar
  7. 7.
    Smythe J, Armitage S, McDonald D, Pamphilon D, Guttridge M, Brown J, et al. Directed sibling cord blood banking for transplantation: the 10-year experience in the national blood service in England. Stem Cells. 2007;25:2087–93.PubMedCrossRefGoogle Scholar
  8. 8.
    Lauber S, Latta M, Kluter H, Muller-Steinhardt M. The Mannheim cord blood bank: experiences and perspectives for the future. Transfus Med Hemother. 2010;37:90–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Bizzetto R, Bonfim C, Rocha V. Outcomes after related and unrelated umbilical cord blood transplantation for heredity bone marrow failure syndromes other than Fanconi anemia. Haematologica. 2011;96:134–41.PubMedCrossRefGoogle Scholar
  10. 10.
    Cohen YC, Scaradavou A, Stevens CE. Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. Bone Marrow Transplant. 2011;46:70–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Kurtzberg J, Prasad VK, Carter SL. Results of Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood. 2008;112:4318–27.PubMedCrossRefGoogle Scholar
  12. 12.
    Eapen M, Rocha R, Sanz G, Scaradavou A, Zhang M, Arcese W, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol. 2010;11:653–60.PubMedCrossRefGoogle Scholar
  13. 13.
    Brunstein CG, Miller JS, Cao Q. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood. 2011;117:1061–70.PubMedCrossRefGoogle Scholar
  14. 14.
    Verneris MR, Brunstein CG, Barker J, MacMillan ML. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood. 2009;114:4293–99.PubMedCrossRefGoogle Scholar
  15. 15.
    Johansen KA, Schneider JF, McCaffree MA, Woods GL. Efforts of the United States’ National Marrow Donor Program and Registry to improve utilization and representation of minority donors. Transfus Med. 2008;18:250–59.PubMedCrossRefGoogle Scholar
  16. 16.
    Moise Jr KJ. Umbilical cord stem cells. Obstet Gynecol. 2005;106:1393–407.PubMedCrossRefGoogle Scholar
  17. 17.
    Salfilippo JS, Barnhard Y, Bahceci E, Bayer-Zwirello L, Donnenfeld AE, Mason BA et al. Family cord blood banking: What you need to know? OBG Management (Suppl). Nov. 2007; S1-S8.Google Scholar
  18. 18.
    Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174–78.PubMedCrossRefGoogle Scholar
  19. 19.
    Rubinstein P, Taylor PE, Scaradavou A, Adamson JW, Migliaccio G, Emanuel D, et al. Unrelated placental blood for bone marrow reconstitution: organization of the placental blood program. Blood Cells. 1994;20:587–96.PubMedGoogle Scholar
  20. 20.
    Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 1996;335:157–66.PubMedCrossRefGoogle Scholar
  21. 21.
    Rubinstein P. Cord blood banking for clinical transplantation. Bone Marrow Transplant. 2009;44:635–42.PubMedCrossRefGoogle Scholar
  22. 22.
    Navarrete C, Contreras M. Cord blood banking. A historical perspective. Br J Haematol. 2009;147:236–45.PubMedCrossRefGoogle Scholar
  23. 23.
    Garcia J. Allogeneic unrelated cord blood banking worldwide: an update. Transfus Apher Sci. 2010;42:257–63.PubMedCrossRefGoogle Scholar
  24. 24.
    NETCORD-Fact: Internatioanal Standards for Cord Blood Collection, Processing, Testing, Banking, Selection and Release, 4th ed. Omaha, FACT, 2008. Accessed January 7, 2011.
  25. 25.
    Hollands P, McCauley C. Private cord blood banking: current use and clinical future. Stem Cell Rev. 2009;5:195–03.PubMedCrossRefGoogle Scholar
  26. 26.
    Ballen KK, Barker JN, Stewart SK, Greene MF, Lane TA. Collection and preservation of cord blood for personal use. Biol Blood Marrow Transplant. 2008;14:356–63.PubMedCrossRefGoogle Scholar
  27. 27.
    Johnson FL. Placental blood transplantation and autologous banking–caveat emptor. J Pediatr Hematol Oncol. 1997;19:183–86.PubMedCrossRefGoogle Scholar
  28. 28.
    Greaves M. Pre-natal origins of childhood leukemia. Rev Clin Exp Hematol. 2003;7:233–45.PubMedGoogle Scholar
  29. 29.
    Samuel GN, Kerridge IH, O’Brien TA. Umbilical cord blood banking: public good or private benefit? Med J Aust. 2008;188:533–55.PubMedGoogle Scholar
  30. 30.
    American Academy of Pediatrics Secton on Hematology/Oncology, American Academy of Pediatrics Section on Allergy/Immunology, Lubin BH, Shearer WT. Cord blood banking for potential future tranpslantation. Pediatrics. 2007;119:165–70.PubMedCrossRefGoogle Scholar
  31. 31.
    Sun J, Allison J, McLaughlin C, Sledge L, Waters-Pick B, Wease S, et al. Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders. Transfusion. 2010;50:1980–87.PubMedCrossRefGoogle Scholar
  32. 32.
    Yang H, Loutfy MR, Mayerhofer S, Shuen P. Factors affecting banking quality of umbilical cord blood for transplantation. Transfusion. 2011;51:286–92.CrossRefGoogle Scholar
  33. 33.
    Broxmeyer HE, Srour EF, Hangoc G, Cooper S, Anderson SA, Bodine DM. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci USA. 2003;100:645–50.PubMedCrossRefGoogle Scholar
  34. 34.
    Reagan DM, Wofford JD, Wall DA. Comparison of cord blood thawing methods on cell recovery, potency, and infusion. Transfusion. 2010;50:2670–75.CrossRefGoogle Scholar
  35. 35.
    Wofford JD. Adult transplant outcomes, single versus pooled blood transplants. Biol Blood Marrow Transplant. 2005;11(Suppl1):2.CrossRefGoogle Scholar
  36. 36.
    Beatty PG, Boucher KM, Mori M, Milford EL. Probability of finding HLA-mismatched related or unrelated marrow or cord blood donors. Hum Immunol. 2000;61:834–40.PubMedCrossRefGoogle Scholar
  37. 37.
    Thornley I, Eapen M, Sung L, Lee SJ, Davies SM, Joffe S. Private cord blood banking: experiences and views of pediatric hematopoietic cell transplantation physicians. Pediatrics. 2009;123:1011–17.PubMedCrossRefGoogle Scholar
  38. 38.
    Vellodi A. Lysosomal storage disorders. Br J Haematol. 2005;128:413–31.PubMedCrossRefGoogle Scholar
  39. 39.
    Whitley CB, Belani KG, Chang PN, Summers CG, Blazar BR, Tsai MY, et al. Long-term outcome of Hurler syndrome following bone marrow transplantation. Am J Med Genet. 1993;46:209–18.PubMedCrossRefGoogle Scholar
  40. 40.
    Peters C, Shapiro EG, Anderson J, Henslee-Downey PJ, Klemperer MR, Cowan MJ, et al. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood. 1998;91:2601–08.PubMedGoogle Scholar
  41. 41.
    Peters C, Charnas LR, Tan Y, Ziegler RS, Shapiro EG, DeFor T, et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood. 2004;104:881–88.PubMedCrossRefGoogle Scholar
  42. 42.
    Krivit W, Pierpont ME, Ayaz K, Tsai M, Ramsay NK, Kersey JH, et al. Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24 months after transplantation. N Engl J Med. 1984;311:1606–11.PubMedCrossRefGoogle Scholar
  43. 43.
    Prasad VK, Kurtzberg J. Emerging trends in transplantation of inherited metabolic diseases. Bone Marrow Transplant. 2008;41:99–08.PubMedCrossRefGoogle Scholar
  44. 44.
    McKenna DH, Brunstein CG. Umbilical cord blood: current status and future directions. Vox Sang. 2011;100:150–62.PubMedCrossRefGoogle Scholar
  45. 45.
    McGuckin CP, Forraz N, Baradez MO, Navran S, Zhao J, Urban R, et al. Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif. 2005;38:245–55.PubMedCrossRefGoogle Scholar
  46. 46.
    Sanchez-Ramos JR. Neural cells derived from adult bone marrow and umbilical cord blood. J Neurosci Res. 2002;69:880–93.PubMedCrossRefGoogle Scholar
  47. 47.
    Newcomb JD, Willing AE, Sanberg PR. Umbilical cord blood cells. Meth Mol Biol. 2009;549:119–36.CrossRefGoogle Scholar
  48. 48.
    Park DH, Borlongan CV, Willing AE, Eve DJ, Cruz LE, Sanberg CD, et al. Human umbilical cord blood cell grafts for brain ischemia. Cell Transplant. 2009;18:985–98.PubMedCrossRefGoogle Scholar
  49. 49.
    Copeland N, Harris D, Gaballa MA. Human umbilical cord blood stem cells, myocardial infarction and stroke. Clin Med. 2009;9:342–45.PubMedGoogle Scholar
  50. 50.
    Sanberg PR, Eve DJ, Willing AE, Garbuzova-Davis S, Tan J, Sanberg CD et al. The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells. Cell Transplant. 2010; Sep 30 [Epub ahead of print].Google Scholar
  51. 51.
    Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 2001;32:2682–88.PubMedCrossRefGoogle Scholar
  52. 52.
    Ende N, Chen R. Parkinson’s disease mice and human umbilical cord blood. J Med. 2002;33:173–80.PubMedGoogle Scholar
  53. 53.
    Ende N, Chen R, Ende-Harris D. Human umbilical cord blood cells ameliorate Alzheimer’s disease in transgenic mice. J Med. 2001;32:241–47.PubMedGoogle Scholar
  54. 54.
    Ende N, Chen R. Human umbilical cord blood cells ameliorate Huntington’s disease in transgenic mice. J Med. 2001;32:231–40.PubMedGoogle Scholar
  55. 55.
    Chen R, Ende N. The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. J Med. 2000;31:21–30.PubMedGoogle Scholar
  56. 56.
    Di Campli C, Piscaglia AC, Pierelli L, Rutella S, Bonanno G, Alison MR, et al. A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. Dig Liver Dis. 2004;36:603–13.PubMedCrossRefGoogle Scholar
  57. 57.
    Ende N, Chen R, Reddi AS. Effect of human umbilical cord blood cells on glycemia and insulitis in type1diabetic mice. Biochem Biophys Res Commun. 2004;325:665–69.PubMedCrossRefGoogle Scholar
  58. 58.
    Zhao Y, Mazzone T. Human cord blood stem cells and the journey to a cure for type 1 diabetes. Autoimmun Rev. 2010;10:103–07.PubMedCrossRefGoogle Scholar
  59. 59.
    Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA. 2005;102:11474–79.PubMedCrossRefGoogle Scholar
  60. 60.
    Arien-Zakay H, Lazarovici P, Nagler A. Tissue regeneration potential in human umbilical cord blood. 2010;23:291–303.Google Scholar
  61. 61.
    Forraz N, McGuckin CP. The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine. 2011;44(Suppl 1):66–9.Google Scholar
  62. 62.
    US National Institues of Health. Umbilical cord blood infusion to treat type 1 diabetes., NCT0030544. Accessed January 7, 2011.
  63. 63.
    National Guidelines Clearing House. Cord blood banking for potential future transplantation. Accessed January 7, 2011.

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Departments of Psychiatry & Behavioral Sciences and PediatricsKansas University Medical CenterKansas CityUSA
  2. 2.Community Blood Center of Greater Kansas CityKansas CityUSA

Personalised recommendations